On a page covering TOPIX index information and market trends, Daikin Industries is reported to have raised its forecast for the fiscal year ending March 2027, while SymBio Pharmaceuticals is reported to have reached an agreement on a UK marketing-authorization application related to brincidofovir.
TOPIX index information and the world's major stock indexes are displayed in a list, with a section provided for checking each index's performance.
In the section on stock movements, Daikin Industries is reported to have raised its earnings forecast for the fiscal year ending March 2027. The expansion of high-value-added products is cited as a factor.
SymBio Pharmaceuticals is also described as having reached an agreement on a UK marketing-authorization application for brincidofovir, in news that may have affected the company's share price.